Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Christophe Laurent is a leading figure in hepatopancreatobiliary (HPB) surgery, with a focused expertise in minimally invasive pancreatic procedures. His most impactful work centers on understanding and mitigating the risks of conversion during minimally invasive left pancreatectomy (MILP). In a landmark 2025 study, Dr. Laurent identified key risk factors for conversion and developed a predictive Conversion Risk Score (CRS), a tool that directly enhances preoperative planning and patient counseling. This research, which has already garnered 4 citations, critically assessed the association between conversion and severe postoperative complications, addressing a core challenge in the field. By quantifying the 15-30% conversion rate observed in MILP, Dr. Laurent’s contributions provide surgeons with actionable data to improve outcomes. His work bridges the gap between technical innovation and patient safety, establishing him as a key voice in advancing the safety and efficacy of minimally invasive pancreatic surgery.